• News
  • Atriva Therapeutics announces first closing of series A financing round

Wirtschaftswoche: 1,25 Mio. Euro für den Kampf gegen Viren

You can read it here...


Atriva Therapeutics GmbH
Christophstr. 32, 72072 Tübingen

+49 (0)7071 8597673

In order to be able to design our website in the best possible way and to continuously improve it, we are using cookies. By continuing to use our website, you permit the use of cookies. More information can be found in our data protection rules.
Data Protection Rules I Agree